The goal of this secret endeavor — dubbed E5 — is to measure how much glucose is in someone’s body without needing to prick the skin for blood. After hitting major milestones recently, the company now believes it could eventually bring glucose monitoring to market, according to people familiar with the effort.

Les fabricants d’insuline ont coutume d’indiquer que les flacons non ouverts d’insuline doivent être conservés au réfrigérateur à une température comprise entre 2°C et 8°C et qu’un flacon déjà ouvert ne doit pas être exposé à des températures supérieures à 25°C-30°C pendant sa durée d’utilisation qui, selon le produit, peut varier de dix jours à huit semaines. Les fabricants recommandent de se débarrasser de l’insuline sortie du réfrigérateur pendant une période spécifiée, que le flacon ait été déjà ouvert ou non et pas encore utilisé. Pour la majorité des produits, ce délai est de quatre semaines.

People with diabetes must consume beer with caution. Read on to know more about the relationship between beer and diabetes.

A glucose sensor is placed under the skin to automatically calculate, with an algorithm, how much insulin to deliver via a pump. This means people with type 1 diabetes no longer have to closely monitor levels of sugar in their blood manually and take daily injections. They can also monitor readings on their smartphones through a system where they upload the number of carbohydrates estimated to be consumed during a meal.

Clinical depression is associated with poorer adherence to hypoglycaemic medication in patients with diabetes mellitus, leading to poorer glycaemic control, diabetes management, and increased complications. The main aim of the TELE-DD trial was to demonstrate the efficacy of a proactive and psychoeducational telephonic intervention based on motivational interviewing and collaborative care to reduce nonadherence and improve prognosis in individuals with diabetes mellitus and concurrent depression.

Prolonged loneliness can lead to type-2 diabetes, research suggests. An absence of deep, positive relationships is the key factor, rather than a simple lack of contact.

Using the functionalities of Insulclock resulted in a 13.9% increase in the total number of insulin injections in the active group mainly due to an improvement in the doses taken on time (13.5%). The increased number of mistimed doses in this group probably reflects a rescue of otherwise lost injections.

People living with diabetes in the UK who use Abbott’s FreeStyle LibreLink app with FreeStyle Libre glucose sensing technology, can now connect it to Novo Nordisk’s smart connected pens.

The FDA is alerting medical device users about a cybersecurity risk for the Medtronic MiniMed 600 Series Insulin Pump System (for example: MiniMed 630G and MiniMed 670G). There is a potential issue associated with the communication protocol for the pump system that could allow unauthorized access to the pump system. If unauthorized access occurs, the pump’s communication protocol could be compromised, which may cause the pump to deliver too much or too little insulin.

A complete overview of the increase of diabetes in the US in terms of statistics, facts, cost, and its overall impact on US citizens.

Plateforme digitale intégrée et collaborative à destination des patients diabétiques insulino-requérants, de leurs aidants et de leurs professionnels de santé.

With 51% of physicians reporting that prior authorizations (PAs) for prescribed branded and specialty medications have significantly expanded over the last five years, PA requirements continue to be a major hurdle for patients and healthcare providers (HCPs) alike.

There are several factors to consider when determining if insulin is the right treatment option for a patient with type 2 diabetes. And once a patient is prescribed insulin therapy, it’s just as important to consider the factors that might lead to nonadherence. That’s why Dr. Charles Turck speaks with Dr. Javier Morales about those factors and how we can improve our patients’ adherence to their insulin regimens.

Obesity is a disease, and America’s healthcare providers and hospital systems must be part of changing how we treat it. That means many of us in the health ecosystem must reexamine how we view patients with excess weight.

The researchers saw that the risk of developing diabetes rose as COVID-19 severity increased. When compared to people who did not have COVID-19 and were not hospitalized or admitted to intensive care, those who were hospitalized or admitted to intensive care had roughly four times the risk.

The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq.

Whether people with diabetes prefer face-to-face, telephone or video consultations depends on whom you ask. We summarise the findings of two published online surveys and report the results of our own paper survey, distributed through the Diabetes Research & Wellness Foundation monthly newsletter, Diabetes Wellness News. Respondents to the online surveys were positive about the benefits of virtual consultations, although there were concerns about confidentiality, safeguarding and identification of emotional issues.

Diabetes-focused life sciences company Zucara Therapeutics released preclinical findings on a daily therapy to slow and prevent plummeting blood glucose levels in Type 1 diabetes patients. The results were published in the peer-reviewed journal, Diabetes, Obesity and Metabolism. Dubbed ZT-01, it could in theory restore the body's ability to release glucagon, an essential component of blood glucose level regulation.

The Diabetes Self-Management Program (DSMP) is a six-week group program for people with type 2 diabetes and is designed to help participants manage their diabetes symptoms including tiredness, pain, and emotional issues by helping them learn skills to better manage their diabetes day-to-day like action planning, problem-solving and decision making. This program is also beneficial for caregivers and are encouraged to enroll. DSMP is an evidence-based program developed at Stanford University and now managed by the Self-Management Resource Center. Participants will receive a free Living a Healthy Life with Chronic Conditions book and a relaxation CD/MP3 for enrolling.

We propose a prototype for a dashboard summary report of glucose, insulin, meals, and activity data intended for providers and patients on MDI using connected pens and CGM. Our goal is to stimulate development of a standardized approach.